| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | US20100098676 Synergistic anti-inflammatory and antioxidant dietary supplement compositions |
| 04/22/2010 | US20100098629 Novel Amides Acting on the Adenosine Receptors |
| 04/22/2010 | DE202004021680U1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition |
| 04/22/2010 | CA2741024A1 Spiro-oxindole compounds and their use as therapeutic agents |
| 04/22/2010 | CA2740614A1 New 2-amidothiadiazole derivatives |
| 04/22/2010 | CA2740557A1 Annexin and its use to treat inflammatory disorders |
| 04/22/2010 | CA2740484A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | CA2739936A1 Pharmaceutical compositions with attenuated release of phenolic opioids |
| 04/22/2010 | CA2737754A1 Co-crystals of tramadol and nsaids |
| 04/22/2010 | CA2735834A1 A medicinal product and treatment |
| 04/21/2010 | EP2177616A1 Soluble zcytor 11 cytokine receptors |
| 04/21/2010 | EP2177530A1 Octapeptide having antiangiogenic activity |
| 04/21/2010 | EP2177521A1 New 2-Amidothiadiazole Derivatives |
| 04/21/2010 | EP2177517A1 Amino substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimide for reducing TNF alpha levels |
| 04/21/2010 | EP2177230A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 04/21/2010 | EP2177215A1 Co-crystals of tramadol and NSAIDs |
| 04/21/2010 | EP2176255A1 Andrographolide derivatives and use thereof in manufacture of medicaments |
| 04/21/2010 | EP2176238A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 04/21/2010 | EP2176219A1 Novel compounds as cannabinoid receptor ligands |
| 04/21/2010 | EP2176208A1 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 04/21/2010 | EP2175886A1 Combination methods and compositions for treatment of neuropathic pain |
| 04/21/2010 | EP2175859A1 Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation |
| 04/21/2010 | EP2175728A1 Sodium channel inhibitors |
| 04/21/2010 | EP2029602B1 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 04/21/2010 | EP1887005B1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof |
| 04/21/2010 | EP1761494B1 Chemical compounds i |
| 04/21/2010 | EP1479670B1 Novel fused ring indazole compounds |
| 04/21/2010 | EP1471887B1 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | EP1268477B1 Substituted beta-carbolines with ikb-kinase inhibiting activity |
| 04/21/2010 | EP1231930B1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 04/21/2010 | EP0870033B1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 04/21/2010 | CN1927250B Pharmaceutical composition, its preparation method and application |
| 04/21/2010 | CN1891267B Chinese medicine for treating atrophic arthritis |
| 04/21/2010 | CN1854134B Piperazine compounds, their preparation method and pharmaceutical composition containing same |
| 04/21/2010 | CN1839974B Medicine composition for treating rheumatoid disease and method for preparing the same |
| 04/21/2010 | CN1761462B Patch containing nonsteroidal antiinflammatory and analgesic agent |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN1689628B Medical purpose of creat extract |
| 04/21/2010 | CN1686424B Medicinal composition containing scutellaria and bupleurum and its preparation method |
| 04/21/2010 | CN101696243A Human genetic engineering antibody TRD 109 as well as preparation method and application thereof |
| 04/21/2010 | CN101696234A Polypeptide for resisting rheumatoid arthritis and application thereof in pharmacy |
| 04/21/2010 | CN101696205A 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition |
| 04/21/2010 | CN101696183A (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof |
| 04/21/2010 | CN101695558A Traditional Chinese medicinal composition for treating traumatic injury and rheumatism paralysis and preparation method thereof |
| 04/21/2010 | CN101695525A Chinese medicinal recovery mat, Chinese medicinal pillow and external application packet of health-care bag for preventing and treating various aches |
| 04/21/2010 | CN101695503A Quality control method of pediatric paracetamol, atificial cow-bezoar and chlorphenamine maleate effervescent tablets |
| 04/21/2010 | CN101695374A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/21/2010 | CN101209276B China elder medicinal liqueur for expelling wind dissipating blood stasis and activating collateral flow |
| 04/21/2010 | CN101152465B Oral liquid for anti-fever and smoothing asthma of hyperpyrexia syndrome and its preparation method |
| 04/21/2010 | CN101152378B Externally used traditional Chinese medicine preparation for diminishing the inflammation and reducing the pain |
| 04/21/2010 | CN101129524B Paederia extractive and medical use of the same |
| 04/21/2010 | CN101074259B Saponin compound, its production and use |
| 04/21/2010 | CN101037465B Saponins and preparation method and application |
| 04/21/2010 | CN101002866B Traditional Chinese medicine for treating animal injuries |
| 04/20/2010 | US7700763 3-triazolyl-galactoside inhibitors of galectins |
| 04/20/2010 | US7700657 Vitamin D analogs |
| 04/20/2010 | US7700593 Imidazo- and triazolo-pyridine compounds and methods of use thereof |
| 04/20/2010 | US7700591 to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700557 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 04/20/2010 | US7700368 plant extracts; obtaining ethanolic solution, passing through column of activated charcoal, and collecting the eluate, removing solvent by rotary evaporation, redissolving in methanol, filtering |
| 04/20/2010 | US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders |
| 04/20/2010 | US7700122 Topical compositions comprising an opioid analgesic and an NMDA antagonist |
| 04/20/2010 | US7700085 Administering an agent which inhibits binding of advanced glycation endproducts to any of their receptors; wound healing |
| 04/20/2010 | CA2515366C Compositions and methods to modulate immune and inflammatory responses |
| 04/20/2010 | CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 04/20/2010 | CA2448356C N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 04/20/2010 | CA2417935C Anti-inflammatory medicament |
| 04/20/2010 | CA2362331C Epoxide hydrolase complexes and methods therewith |
| 04/20/2010 | CA2361587C Methods and compositions to enhance white blood cell count |
| 04/20/2010 | CA2359573C Conjugates of colony stimulating factors for targeting and imaging infection and inflammation |
| 04/20/2010 | CA2352572C Humanized antibodies to gamma-interferon |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/20/2010 | CA2229078C Pharmaceutical composition containing il-10 |
| 04/20/2010 | CA2134756C Selectin variants |
| 04/20/2010 | CA1341603C Acidic polysaccharide esters and process for their preparation |
| 04/15/2010 | WO2010042886A2 Pyrone analogs for therapeutic treatment |
| 04/15/2010 | WO2010042646A1 Aza- and diaza-phthalazine compounds as p38 map kinase modulators and methods of use thereof |
| 04/15/2010 | WO2010042445A1 Carbazole compounds and therapeutic uses of the compounds |
| 04/15/2010 | WO2010042212A2 Methods for treating or preventing pain using spicamycin derivatives |
| 04/15/2010 | WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 04/15/2010 | WO2010040843A2 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds |
| 04/15/2010 | WO2010040272A1 Amide compounds, their pharmaceutical compositions, their preparation and their use |
| 04/15/2010 | WO2010018837A3 Protein cross-linking inhibitor |
| 04/15/2010 | WO2010018836A3 Polyglutamine aggregation inhibitor |
| 04/15/2010 | WO2010006169A3 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 04/15/2010 | WO2010006135A3 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 04/15/2010 | WO2010006086A3 Kinase inhibitors and methods of use |
| 04/15/2010 | WO2010005558A3 Pi3k isoform selective inhibitors |
| 04/15/2010 | WO2009146218A3 Compounds including an anti-inflammatory pharmacore and methods of use |
| 04/15/2010 | WO2009143018A3 Pyrrolo [2, 3-d] pyrimidines as fm and kit kinase modulators |
| 04/15/2010 | WO2009071753A8 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 04/15/2010 | US20100094408 Drug-Delivery Endovascular Stent and Method for Treating Restenosis |
| 04/15/2010 | US20100094015 Indazole having analgesic activity |
| 04/15/2010 | US20100093870 Herbal medicaments for the treatment of neurocerebrovascular disorders |
| 04/15/2010 | US20100093839 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia |
| 04/15/2010 | US20100093838 Regulation of angiogenesis with zinc finger proteins |